{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:32:30Z","timestamp":1774963950881,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24fk0410062h0001"],"award-info":[{"award-number":["24fk0410062h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jiac.2025.102806","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:23:04Z","timestamp":1756768984000},"page":"102806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["HIV-associated multicentric Castleman disease with Kaposi sarcoma: A case report with 120-week follow-up of HHV-8 after remission"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9396-9097","authenticated-orcid":false,"given":"Seitaro","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0547-1026","authenticated-orcid":false,"given":"Takato","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4451-599X","authenticated-orcid":false,"given":"Takahiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102806_bib1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2025.102806_bib2","article-title":"Castleman disease: a rare lymphoproliferative disorder with diverse clinical presentation, diagnosis, and treatment approach","volume":"16","author":"Patel","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jiac.2025.102806_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/14787210.2023.2247161","article-title":"Clinical management of kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies","volume":"21","author":"Patel","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2025.102806_bib4","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3109\/10428194.2014.953145","article-title":"Use of a claims database to characterize and estimate the incidence rate for castleman disease","volume":"56","author":"Munshi","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jiac.2025.102806_bib5","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/S2352-3026(16)00006-5","article-title":"Idiopathic multicentric Castleman's disease: a systematic literature review","volume":"3","author":"Liu","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jiac.2025.102806_bib6","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/S2352-3018(20)30118-1","article-title":"Epidemiology of haematological malignancies in people living with HIV","volume":"7","author":"Kimani","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jiac.2025.102806_bib7","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","article-title":"High incidence of kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric castleman disease","volume":"99","author":"Oksenhendler","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2025.102806_bib8","first-page":"25","article-title":"Multicentric Castleman's disease in HIV infection: a systematic review of the literature","volume":"10","author":"Mylona","year":"2008","journal-title":"AIDS Rev"},{"key":"10.1016\/j.jiac.2025.102806_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6890-8-7","article-title":"Pathology of rituximab-induced kaposi sarcoma flare","volume":"8","author":"Pantanowitz","year":"2008","journal-title":"BMC Clin Pathol"},{"key":"10.1016\/j.jiac.2025.102806_bib10","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1182\/blood-2014-07-586800","article-title":"Rituximab plus liposomal doxorubicin in HIV-Infected patients with KSHV-Associated multicentric castleman disease","volume":"124","author":"Uldrick","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2025.102806_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdn697","article-title":"The role of immune suppression and HHV-8 in the increasing incidence of HIV-Associated multicentric Castleman's disease","volume":"20","author":"Powles","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jiac.2025.102806_bib12","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.4081\/rt.2012.e40","article-title":"HIV-Associated multicentric Castleman's disease","volume":"4","author":"Naime","year":"2012","journal-title":"Rare Tumors"},{"key":"10.1016\/j.jiac.2025.102806_bib13","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","article-title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric castleman disease","volume":"132","author":"van Rhee","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2025.102806_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QCO.0b013e3283486d04","article-title":"Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment","volume":"24","author":"Gantt","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102806_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood-2011-02-335620","article-title":"Plasma HHV8 DNA predicts relapse in individuals with HIV-Associated multicentric castleman disease","volume":"118","author":"Stebbing","year":"2011","journal-title":"Blood"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2500203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2500203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:38:31Z","timestamp":1772883511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2500203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1341321X2500203X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102806","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-associated multicentric Castleman disease with Kaposi sarcoma: A case report with 120-week follow-up of HHV-8 after remission","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102806"}}